MobiHealth News June 7, 2021
A new white paper from HIMSS suggests that the smartphone can hold the key to delivering capacity and enabling an innovative approach to rapid antigen testing as governments continue to wrestle with the impact of the COVID-19 pandemic.
The white paper outlines a roadmap for the way in which a fully integrated mobile rapid antigen testing strategy can play a central role in the ongoing surveillance required to contain the spread of COVID-19 as governments accelerate their vaccination programmes.
The paper, which is supported by iXensor, the pioneer of mobile health that developed the world’s first FDA-approved smartphone camera-based blood test, explores the impact that the use of COVID-19 rapid antigen testing has already had on infection rates where it...
Today's Sponsors
Today's Sponsor